7
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Call for Papers: Green Renal Replacement Therapy: Caring for the Environment

      Submit here before July 31, 2024

      About Blood Purification: 3.0 Impact Factor I 5.6 CiteScore I 0.83 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      Spontaneous Arterial Thrombosis Associated with Nephrotic Syndrome: Case Report and Review of the Literature

      case-report
      , ,
      Nephron
      S. Karger AG
      Femoral artery, Heparin, Nephrotic syndrome, Thrombosis, Warfarin

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hypercoagulability is a recognized complication of the nephrotic syndrome which commonly affects the venous system. Arterial thrombosis is very rare. Multiple factors contribute to the predisposition to thromboembolism in this condition. This report deals with a case of femoral artery thrombosis which responded well to thrombectomy and a short course of anticoagulant therapy. In spite of several exacerbations of his disease, our patients had no recurrence of thrombosis. Review of the literature reveals high rates of limb loss and recurrence of thrombosis. We, therefore, feel that it is important to emphasize this rare entity in view of the associated morbidity.

          Related collections

          Author and article information

          Journal
          NEF
          Nephron
          10.1159/issn.1660-8151
          Nephron
          S. Karger AG
          1660-8151
          2235-3186
          1995
          1995
          18 December 2008
          : 71
          : 1
          : 95-97
          Affiliations
          Department of Surgery, Easton Hospital, Easton, Pa., USA
          Article
          188680 Nephron 1995;71:95–97
          10.1159/000188680
          8538855
          1b9c49e8-9bb2-41da-adc8-fdc59cbdc9f8
          © 1995 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 16 September 1994
          Page count
          Pages: 3
          Categories
          Case Report

          Cardiovascular Medicine,Nephrology
          Femoral artery,Heparin,Nephrotic syndrome,Thrombosis,Warfarin
          Cardiovascular Medicine, Nephrology
          Femoral artery, Heparin, Nephrotic syndrome, Thrombosis, Warfarin

          Comments

          Comment on this article